| Dr Peter T Demos, MD | |
|
125 Liberty St, Ste 403, Springfield, MA 01103-1109 | |
| (413) 739-6611 | |
| Not Available |
| Full Name | Dr Peter T Demos |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 44 Years |
| Location | 125 Liberty St, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619977402 | NPI | - | NPPES |
| J06761 | Other | MA | PROVIDER NUMBER |
| 11753 | Other | MA | HNE PROVIDER NUMBER |
| 725076 | Other | MA | TUFTS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 58416 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Entity Name | Peter T Demos Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669090445 PECOS PAC ID: 9537576962 Enrollment ID: O20210330002548 |
News Archive
A team of Canadian and Japanese researchers has identified the genetic mutation responsible for glycogen storage disease type IIIa in Inuit in northern Quebec, Canada, in a study published in CMAJ (Canadian Medical Association Journal).
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Adults with extreme obesity have increased risks of dying at a young age from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three countries.
Gene therapy research has reached a critical phase. Already practised on humans as part of strictly controlled experiments, gene therapy promises to become a widely available form of treatment for injury and disease.
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
› Verified 4 days ago
| Entity Name | Demos Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730804634 PECOS PAC ID: 5890169882 Enrollment ID: O20230314001487 |
News Archive
A team of Canadian and Japanese researchers has identified the genetic mutation responsible for glycogen storage disease type IIIa in Inuit in northern Quebec, Canada, in a study published in CMAJ (Canadian Medical Association Journal).
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Adults with extreme obesity have increased risks of dying at a young age from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three countries.
Gene therapy research has reached a critical phase. Already practised on humans as part of strictly controlled experiments, gene therapy promises to become a widely available form of treatment for injury and disease.
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter T Demos, MD 125 Liberty St, Ste 403, Springfield, MA 01103-1109 Ph: (413) 739-6611 | Dr Peter T Demos, MD 125 Liberty St, Ste 403, Springfield, MA 01103-1109 Ph: (413) 739-6611 |
News Archive
A team of Canadian and Japanese researchers has identified the genetic mutation responsible for glycogen storage disease type IIIa in Inuit in northern Quebec, Canada, in a study published in CMAJ (Canadian Medical Association Journal).
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Adults with extreme obesity have increased risks of dying at a young age from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three countries.
Gene therapy research has reached a critical phase. Already practised on humans as part of strictly controlled experiments, gene therapy promises to become a widely available form of treatment for injury and disease.
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
› Verified 4 days ago
Michael Loosemore, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St Ste 5, New England Dermatology & Laser Center, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 | |
Nadine P Wenner, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3455 Main St, Ste 5, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 | |
Sheila Greenlaw, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St Ste 5, New England Dermatology & Laser Center, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 | |
Dr. Michael D Horwich, MD, PHD Dermatology Medicare: Medicare Enrolled Practice Location: 3455 Main St Ste 5, New England Dermatology & Laser Center, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 | |
David Wartman, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St, Ste. # 5, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 | |
Mark A Blumberg, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St, Suite 5, Springfield, MA 01107 Phone: 413-733-9600 Fax: 413-732-6534 |